Skip to content
  • Saturday, 12 September 2026
  • 6:31 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Ultraheavy Atomic Nuclei May Solve the Longstanding Mystery of Ultrahigh Energy Cosmic Rays and the Amaterasu Particle
Advanced Materials Science

Ultraheavy Atomic Nuclei May Solve the Longstanding Mystery of Ultrahigh Energy Cosmic Rays and the Amaterasu Particle

Nila Kartika Wati Jun 15, 2026 0

The detection of the Amaterasu particle in 2021 sent shockwaves through the global astrophysical community, marking one of the most…

Read More
Advanced Materials Science

DAMPE Space Telescope Unveils Universal Pattern in Cosmic Ray Nuclei Challenging Longstanding Astrophysical Models

Nila Kartika Wati Jun 2, 2026 0

The Dark Matter Particle Explorer (DAMPE) satellite has provided a definitive breakthrough in high-energy astrophysics by identifying a universal "spectral…

Read More
Advanced Materials Science

Evidence for the Formation of Eta-Prime Mesic Nuclei and Its Implications for the Origin of Mass in the Universe

Nila Kartika Wati May 3, 2026 0

The fundamental question of why matter possesses mass remains one of the most profound mysteries in modern physics, transcending the…

Read More
Advanced Materials Science

Evidence for the Formation of η’-Mesic Nuclei and Its Implications for the Origin of Particle Mass

Nila Kartika Wati Apr 26, 2026 0

In a landmark achievement for the field of subatomic physics, an international collaboration of researchers has announced the first experimental…

Read More
Advanced Materials Science

University of Tennessee Nuclear Physicists Reveal Breakthrough Discoveries in the Formation of Heavy Elements and Exotic Atomic Nuclei

Nila Kartika Wati Mar 22, 2026 0

The origin of heavy elements like gold, platinum, and uranium has long remained one of the most profound mysteries in…

Read More
Parabilis Medicines Aims for $475 Million Nasdaq IPO to Fund Pivotal Desmoid Tumour Trial and Pipeline ExpansionThe Long Shadow of September 11: Twenty-Five Years of Health Consequences for Survivors and RespondersScience News: Empowering Public Understanding of Science, Medicine, and Technology Since 1921Daiichi Sankyo and Tempus AI collaborate on ADC clinical development
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetLLMOps in 2026: The 10 Tools Every Team Must Have
Attention Unleashed: Rethinking ADHD as a Conduit for Creative Innovation in the Modern Neurological LandscapeHarmonic Shielding: Harvard Researchers Use Microscopic Sound Waves to Protect Fragile Quantum InformationSolstice Oncology Secures $225m in Series A Financing to Advance Neoadjuvant Immuno-Oncology Therapy PorustobartScience News: A Century of Independent Scientific Journalism and the Evolution of Public Literacy
YOU MAY HAVE MISSED
Neuroscience & Brain Research
Attention Unleashed: Rethinking ADHD as a Conduit for Creative Innovation in the Modern Neurological Landscape
Rifan Muazin Sep 12, 2026
Advanced Materials Science
Harmonic Shielding: Harvard Researchers Use Microscopic Sound Waves to Protect Fragile Quantum Information
Nila Kartika Wati Sep 12, 2026
Pharmaceutical R&D
Solstice Oncology Secures $225m in Series A Financing to Advance Neoadjuvant Immuno-Oncology Therapy Porustobart
Teuku Ryan Sep 12, 2026
Environmental & Analytical Chemistry
Science News: A Century of Independent Scientific Journalism and the Evolution of Public Literacy
Abdurrohim Arsyad Sep 12, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ